Skip to main content
logo
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
122.60
+0.09 (0.07%)
Oct 29, 2026, 4:00 PM EDT - Market closed

Kymera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,1946,2252,6061,4131,3693,259
Market Cap Growth
134.32%138.91%84.43%3.16%-57.98%18.59%
Enterprise Value
8,6255,3301,7831,0597912,666
Last Close Price
122.6077.8140.2325.4624.9663.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-34.2734.2734.2734.2734.27
PS Ratio
99.71158.7555.3517.9829.2544.75
PB Ratio
6.483.943.123.582.797.09
P/TBV Ratio
6.313.943.123.582.797.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
84.36135.9337.8713.4716.8836.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.050.110.210.040.04
Net Debt / Equity Ratio
-0.97-0.97-0.91-0.89-1.11-1.20
Net Debt / EBITDA Ratio
3.944.543.042.153.405.55
Net Debt / FCF Ratio
5.436.563.682.563.484.21
Asset Turnover
0.070.030.060.130.080.13
Quick Ratio
10.8310.197.214.595.744.78
Current Ratio
11.1310.477.534.735.884.88
Return on Equity (ROE)
-27.29%-25.78%-36.38%-33.21%-32.60%-26.96%
Return on Assets (ROA)
-17.64%-15.88%-20.65%-17.55%-16.67%-11.50%
Return on Capital Employed (ROCE)
-24.10%-20.80%-28.20%-33.80%-30.30%-19.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.96%-5.00%-8.59%-10.40%-11.30%-3.08%
FCF Yield
-2.83%-3.77%-7.96%-9.72%-11.39%-4.01%
Buyback Yield / Dilution
-17.58%-12.59%-28.58%-8.22%-12.39%-176.60%
SEC Filings: 10-K · 10-Q